Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 HKD | +0.88% | -6.56% | -21.92% |
04-03 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
04-03 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |